
Cover image

Volume 224, Issue 9, 1 November 2021
EDITORIAL COMMENTARY
Coronavirus Disease 2019 Severity in Obese Patients May Be Linked to Viral Load and Immune Response
PERSPECTIVES
The Time is Now: A Call for Renewed Support of Infectious Diseases Physician-Scientist Trainees in the Era of Coronavirus Disease 2019
Infectious diseases fellows’ futures have been uniquely imperiled by the pandemic. In this article, we issue a call to action to sustain their careers as the future leaders of infectious diseases inquiry.
REVIEW
Human Immunodeficiency Virus/AIDS in the Era of Coronavirus Disease 2019: A Juxtaposition of 2 Pandemics
Concurrent COVID-19 and HIV/AIDS pandemics pose unprecedented societal, economic, and public health challenges worldwide. Effective responses to these dual pandemics require a novel coordinated and collaborative global effort to accelerate biomedical research and implementation science to operationalize evidence-based interventions expeditiously.
MAJOR ARTICLES AND BRIEF REPORTS
COVID-2019
Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System Beneficiaries
Obesity is correlated with COVID-19 severity, SARS-CoV-2 viral load, and anti-spike IgG antibody responses. These findings offer new pathophysiological insights into the relationship between obesity and COVID-19 severity.
Inflammatory Profiles and Clinical Features of Coronavirus 2019 Survivors 3 Months After Discharge in Wuhan, China
Vascular injury and aberrant proinflammatory cytokine and chemokine levels persisted and were significantly correlated with chest computed tomographic abnormalities and impaired pulmonary function 3 months after hospital discharge in patients recovered from coronavirus disease 2019, especially severe/critical disease.
Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection
Longitudinal follow-up of individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reveals differences in the duration of antibodies to multiple antigens. Mathematical models of antibody waning and statistical algorithms can estimate an individual’s time since SARS-CoV-2 infection, and previous transmission waves in a population.
Quantifying the Impact of COVID-19 Nonpharmaceutical Interventions on Influenza Transmission in the United States
Incidence of influenza A/H1 and B were reduced by more than 60% in the United States during the first 10 weeks following implementation of NPIs. Potential large outbreaks of influenza may occur after the relaxation of NPIs.
VIRUSES
Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus–Seronegative Recipients of the HSV529 Vaccine
Recipients of a herpes simplex virus type 2 (HSV-2) vaccine trial had antibodies to fewer viral epitopes compared with natural infection, HSV gD antibodies in cervicovaginal fluid at one-third the level of those in serum, and antibodies that mediated HSV-2–specific natural killer cell activation.
Antioxidants Associated With Oncogenic Human Papillomavirus Infection in Women
Serum albumin and 4 dietary antioxidants (vitamin A, B2, E, and folate) were inversely associated with high-risk HPV vaginal infection. The nutritional antioxidant score based on these 4 dietary antioxidants was also inversely associated with high-risk and low-risk HPV infection.
Updated Characterization of Poliovirus Transmission in Pakistan and Afghanistan and the Impacts of Different Outbreak Response Vaccine Options
Given the epidemiological situation in Pakistan and Afghanistan in late 2020, using trivalent oral poliovirus vaccine to respond to cases caused by serotype 1 and 2 polioviruses offers substantial benefits.
Rotavirus Genotype Trends and Gastrointestinal Pathogen Detection in the United States, 2014–2016: Results From the New Vaccine Surveillance Network
Rotavirus group A surveillance in 7 US New Vaccine Surveillance Network sites during the 2014–2016 rotavirus season shows genotype G12P[8] as the most common strain over the 3 seasons, but predominance varied by year and study site.
Limited Flavivirus Cross-Reactive Antibody Responses Elicited by a Zika Virus Deoxyribonucleic Acid Vaccine Candidate in Humans
Antibodies elicited by ZIKV DNA vaccination of individuals with no evidence of prior flavivirus experience had a limited capacity to bind or neutralize heterologous flaviviruses. More extensive cross-reactivity was observed in vaccinated individuals with prior flavivirus exposure.
BACTERIA
Endotoxin Acts Synergistically With Clostridioides difficile Toxin B to Increase Interleukin 1β Production: A Potential Role for the Intestinal Biome in Modifying the Severity of C. difficile Colitis
Our study shows that endotoxin acts synergistically with Clostridioides difficile toxin B to increase IL-1β production. This effect varies among endotoxins from different gram-negative organisms and highlights a mechanism by which the gut microbiome can modify C. difficile disease severity.
Ticagrelor Increases Platelet-Mediated Staphylococcus aureus Killing, Resulting in Clearance of Bacteremia
In a patient with persistent methicillin-resistant S. aureus bacteremia associated with a septic aortic thrombus, adjunctive ticagrelor therapy resulted in immediate bacteremia clearance. In vitro experiments demonstrate that ticagrelor’s anti-infective properties are due to boosting of platelet-mediated killing, not antibiotic synergy.
HIV/AIDS
Factors Associated With Being Overweight and Obesity in People Living With Human Immunodeficiency Virus on Antiretroviral Therapy: Socioclinical, Inflammation, and Metabolic Markers
In normal-weighted people with human immunodeficiency virus at combination antiretroviral therapy (cART) initiation, higher body mass index, sub-Saharan African origin, living in a couple, and higher soluble tumor necrosis factor receptor 2 and lower adiponectin concentrations are associated with becoming overweight or obese after 36 months of cART.
Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083
Injectable cabotegravir is highly effective for preventing human immunodeficiency virus infection. Infections can occur despite on-time injections and expected drug concentrations. Integrase strand transfer inhibitor resistance is observed in some cases. Viral load testing may help detect incident infections.
Gag p24 Is a Marker of Human Immunodeficiency Virus Expression in Tissues and Correlates With Immune Response
Continuous expression of HIV protein in lymphoid tissues despite prolonged viral suppression helps explain persistent immune activation and HIV-specific T-cell responses. Measuring HIV protein in tissues will likely be important for understanding mechanisms of persistence and evaluating future cure approaches.
Correlation Between TIGIT Expression on CD8+ T Cells and Higher Cytotoxic Capacity
Our data suggest that subsets of TIGIT+CD8+ T cells do not represent a state of immune exhaustion and maintain an intrinsic capacity to kill targets in human immunodeficiency virus–infected individuals in the absence of active viral replication.
PARASITES
Reduced Birth Weight Caused by Sextuple Drug-Resistant Plasmodium falciparum Infection in Early Second Trimester
In early stages of pregnancy (early second trimester), Plasmodium falciparum infections with the sextuple Pfdhfr/Pfdhps mutant haplotype affect the effectiveness of sulfadoxine-pyrimethamine as intermittent preventive treatment during pregnancy by lowering the birth weight of newborns.
Diminished Circulating Levels of Angiogenic Factors and Rage Ligands in Helminth–Diabetes Comorbidity and Reversal Following Anthelmintic Treatment
Helminth infections are associated with decreased levels of angiogenic factors and their receptors, advanced glycation end products, and their ligands. These alterations are reversed following anthelmintic treatment. Strongyloides stercoralis infection could play a beneficial role by limiting or delaying the type 2 diabetes mellitus–related vascular complications.